Total votes: 9

CogState is a global provider of cognitive testing products and services. Established in 1999 and becoming a publicly listed company on the ASX in 2004. CogState tests use simple but effective technology to detect cognitive change in subjects. The tests begin by taking a baseline measurement from a subject who is then periodically retested in order to detect cognitive change. CogState testing utilises culture-neutral stimuli, which ensures that a wide range of subjects can be tested regardless of their ethnicity, socio-economic background or education. CogState tests are extremely sensitive and their validity has been demonstrated in over 100 peer-reviewed articles.

Due to its market growth CogState recently opened a new office in New Haven, Connecticut to add to its Australian headquarters.

Cash Reserves & Revenue:
Revenues for 2009-2010 were $9.4M (operating profit $0.5M)

Cash reserves at June 30, 2010 totalled $3.1 million

Clinet base: CogState has secured agreements with international tier 1 organisations including Pfizer, GlaxoSmithKline, Abbot, Merck, Lundbeck, The Centers for Disease Control (USA), ALZA Corporation (a member of the Johnson and Johnson group) and Organon USA.

Investors & Start-up: Cogstate was funded by Venture Capital activities in its early stages including GBS Ventures

Products: Their computer based tests (which can be done over the internet) covers such areas as Alzheimers, Dementia, Cognition decreases realted to drugs and concussion. CogState provides products and services to 4 distinct but complementary markets:

1. CogState ClinicalTrials
CogState ClinicalTrials is a total service rather than just a product. The provision of cognitive testing software to multinational pharmaceutical companies is backed up by scientific consulting services, 24-hour technical support and end-to-end project management. CogState's unique DataPoint® technology allows its customers to view clinical trial data in real time - something that has been unheard of previously in this market. Our customers include 5 of the leading top 10 pharmaceutical companies and numerous smaller pharmaceutical and biotech companies.

2. CogState Research
CogState Research is an academically oriented version of the CogState ClinicalTrials software. With the same proven rapidity, sensitivity and validity, this software provides academic researchers with a powerful method of testing cognition at a competitive price. It has been used by institutions such as Yale University, the University of Melbourne and the Australian Government's National Health & Medical Research Council.

3. CogState Sport  & Axons Sports (USA)
CogState Sport is an invaluable computerised tool for the management of concussed professional and amateur athletes. After a player is concussed, CogState Sport allows team management and physicians to monitor the athlete's cognitive abilities against a baseline reading that was taken prior to injury. Due to its sensitivity, this software can detect even the mildest of cognitive impairments that other methods of concussion management are unable to identify. Customers include: FIFA, UK Rugby Football League, teams in The Australian Football League and South African Rugby. Axon Sports is targeting the USA market for high school sports and NFL.

4. CogState WorkPlace
CogState WorkPlace allows employers to comprehensively measure if their employees are fit for duty when it comes to their ability to think and act. Taking only around 8 minutes to complete, it has been proven to be sensitive to the effects of alcohol, fatigue and certain types of drugs. This method of testing is significantly less invasive than existing methods of drug and alcohol testing and therefore can be used as a less invasive step within an OH&S system.